A rapid and sensitive HPLC method for the analysis of metronidazole in human plasma: Application to single dose pharmacokinetic and bioequivalence studies

Daru

Volumn 14, Issue 1, 2006, Pages 15-21

  Emami, Jaber ^a   Ghassami, Neda ^a   Hamishehkar, Hamed ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioavailability; HPLC; Metronidazole; Pharmacokinetics

Indexed keywords

METRONIDAZOLE; PLASMA PROTEIN; RANITIDINE; ZINC SULFATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; PLASMA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SENSIBILITY;

EID: 33745635880     PISSN: 15608115     EISSN: 15608115     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Reynolds JEF. Martindale, The Extra Pharmacopoeia, Vol. 33, The Royal Pharmaceutical Society, Great Britain, London; 2002. p. 594 - 596.
2. Ralf ED. Clinical pharmacokinetics of metronidazole. Clin Pharm 1983; 8:.43-62.
3. th ed., NewYork: Mc Graw - Hill; 2001. p. 1106-1107.
4. Fredricsson B, Hagstrom B, Nord CE, Rane A. Systemic concentrations of metronidazole and its main metabolites after intravenous, oral and vaginal administration. Gyneeol Obstet Invest 1987; 24:200-207.
5. Sattar MA, Sankey MG, Cawley ML, Kaye CM, Holt JE. The penetration of metronidazole into synovial fluid. Postgard Med J 1982; 58:20-24.
6. Nagar H, Berger SA, Hammar B. Penetration of clindamycin and metronidazole into the appendix and peritoneal fluid in children. Eur J Clin Pharmacol 1989; 37:209-210.
7. rd ed. American College of physicians, philadelphia, 1994.
8. Gjerloff C, Arnold E. Pharmacokinetics of intravenous metronidazole in man. Acta Pharmacol Toxicol 1982; 51:132-135.
9. Jensen JC, Gugler R. Single and multiple dose metronidazole kinetics. Clin Pharmacol Ther 1983; 34:481-487.
10. Rubenson A, Rosetzsky A. Single dose prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic study. Eur J Clin Pharmacol 1986; 29: 625-628.
11. Houghton GW, Dennis MJ, Gabriel R. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure. Br J Clin Pharmacol 1985; 19:203-209.
12. Eranko PO, Palva ES, Konno K, Venho VMK. Regulatory control of synonym drug bioavailability: Bioinequivalency of Nifedipine preparations, Pharmaceutic Med 1990; 4:197-205.
13. Emami J, Varshosaz, J, Flamarzian M, Tahvilian R, High performance liquid chromatographic determination, pharmacokinetic and comparative bioavailability studies of cisapride. J Pharm Biomed Anal 2003; 33:513 - 520.
14. Adamovics J. Rapid determination of metronidazole in human serum and urine using a normal-phase high-performance liquid chromatographic column with aqueous solvents. J Chromatogr 1984; 309(2):436-440.
15. Rona K, Simple BG. Liquid chromatographic method for the determination of ornidazole and metronidazole in human serum. J Chromatogr 1987; 420(1):228-230
16. Jessie MJ, Barrett DA, Shaw PN, Spiller RC. Rapid and selective high-performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice. J Chromatogr B- Biomed Appl 1996; 677(2):374-379.
17. Galmier MJ, Frasey AM, Bastide M, Beyssac E, Petit J, Aiache JM, Lartigue-Mattei C. Simple and sensitive method for determination of metronidazole in human serum by high-performance liquid chromatography. J Chromatogr B- Biomed Sci Appl 1998; 720(1-2):239-243.
18. Wibawa JD, Shaw PN, Barrett DA. Quantification of metronidazole in small-volume biological samples using narrow-bore high-performance liquid chromatography. J Chromatogr -B Biomed Sci Appl 2001; 761(2):213-219
19. Venkateshwaran TG, Stewart JT. Determination of metronidazole in vaginal tissue by high-performance liquid chromatography using solid-phase extraction. J Chromatogr-B Biomed Appl 1995;672(2): 300-304
20. Yeung PK, Little R, JiangY, Buckley SJ, Pollak PT, Kapoor H, Veldhuyzen-van-Zanten SJ. A simple high performance liquid chromatography assay for simultaneous determination of omeprazole and metronidazole in human plasma and gastric fluid. J Pharm Biomed Anal. 1998; 17(8):1393-1398.
21. Sorensen LK, Hansen H. Determination of metronidazole and hydroxymetronidazole in trout by a high-performance liquid chromatographic method. Food Addit Contam 2000; 17(3):197-203.
22. Pollak, PT. A liquid chromatography assay for the study of serum and gastric juice metronidazole concentrations in the treatment of Helicobacter pylori. Ther.Drug Monit. 1996; 18(6):678-87.
23. Menelaou A, Somogyi AA, Barclay ML, Bochner F. Simultaneous quantification of amoxycillin and metronidazole in plasma using high-performance liquid chromatography with photodiode array detection. J Chromatogr-B Biomed Sci Appl 1999; 731(2):261-266.
24. th edition; 2002.
25. Westlake WJ. Use of confidence intervals in analysis of comparative bioavailability trials. J Pharm Sci 1972; 61 (8):1340-1341.
26. Rockville MD. FDA guidance on statistical procedures for bioequivalence studies using a standard two-treatment crossover designs, Division of Bioequivalence, office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1992.
27. Chow S. Individual bioequivalence: a review of the FDA draft guidance. Drug lnf J 1999; 33:435-444.
28. Wheeler LA, De-Meo M, Halula M, George L, Heseltine P. Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration. Antimicrob Agents Chemother 1978; 13(2):205-209.
29. Nilsson-Ehle I, Ursing B, Nilsson-Ehle P. Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects. Antimicrob. Agents Chemother 1981; 19(5): 754-60.
30. Yuen KH, Phen KK, Chan KL, Toh WT. Pharmacokinetics and bioequivalent study of a generic metoprolol tablet preparation. Drug Dev Ind Pharm 1998; 24 (10):955-961.